Video Search Results
RESULTS 1-10 of 82
Protalix to Develop More Plant-Cell Drugs, CEO Says
May 7 (Bloomberg) -- David Aviezer, president and chief executive officer of Protalix BioTherapeuticss Inc., talks about the company's first p...
Pfizer Needs More New Products, Butler Says
May 1 (Bloomberg) -- Tony Butler, an analyst at Barclays Capital, talks about Pfizer Inc.'s first-quarter profit and the outlook for the compa...
Novo Nordisk Sees Diabetes Drug Market Expanding
April 27 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about first-quarter profit and the outlook for the wo...
Clal Biotech to Invest in Medical Devices
March 15 (Bloomberg) -- Ruben Krupik, chief executive officer at Clal Biotechnology Industries Ltd., discusses the company's investments. He t...
Vivus President on Qnexa Obesity Drug
Feb. 23 (Bloomberg) -- Peter Tam, president of Vivus Inc., talks about the outlook for the company's Qnexa obesity drug after U.S. Food and Dr...
FDA Crackdown on Viagra-Like Supplements
Dec. 15 (Bloomberg) -- Rock Hard Weekend, a blue-and-white pill touted in ads as a source of “all-natural male enhancement,” had a secret ingr...
FDA Crackdown on Viagra-Like Supplements
Dec. 15 (Bloomberg) -- Rock Hard Weekend, a blue-and-white pill touted in ads as a source of “all-natural male enhancement,” had a secret ingr...
Israel on Payroll Tax Break: Political Capital with Al Hunt
Dec. 10 (Bloomberg) -- Representative Steve Israel, a Democrat from New York, talks with Bloomberg's Al Hunt about President Barack Obama's ef...
Mela's Gulfo Says MelaFind Is `Breakthrough Device'
Nov. 21 (Bloomberg) -- Joseph Gulfo, chief executive officer of Mela Sciences Inc., the maker of the MelaFind melanoma-detection device, talks...
FDA Commissioner Hamburg on Funding
Nov. 11 (Bloomberg) -- U.S. Food and Drug Administration Commissioner Margaret Hamburg says the agency has been "underfunded for decades" even...
